About the Cancer Genome Session
Cancer genome exploration delves deep into the intricate genetic fabric that underpins cancer's origin and progression. By meticulously dissecting the DNA blueprint within cancerous cells, researchers uncover pivotal mutations dictating tumor growth, spread, and resistance to treatment. This genomic scrutiny not only unveils the diverse molecular mechanisms propelling cancer but also heralds a new era of tailored therapies, finely tuned to the individual genetic makeup of patients. Advanced methodologies such as next-generation sequencing unravel the complexity of various cancer types, offering profound insights into potential therapeutic targets and predictive markers. Initiatives like The Cancer Genome Atlas (TCGA) serve as vast treasure troves of genomic data, fueling collaborative endeavors aimed at unraveling cancer's genomic mysteries and revolutionizing oncology. Through relentless exploration of the cancer genome, scientists endeavor to unearth innovative strategies for early detection, precise intervention, and ultimately, the triumph over cancer's formidable grip.
Topics Covered in Cancer Genome
Structural Variants
Copy Number Alterations
Noncoding Mutations
Chromothripsis
Clonal Evolution
Pan-Cancer Analysis
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Genome Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Genome work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Genome research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Genome track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Genome Conference 2027 — FAQs
What is the Cancer Genome track at CIOC 2027?
The Cancer Genome track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Genome. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Genome sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Genome are all welcome — whether presenting or attending.
Can I present my research in the Cancer Genome track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Genome sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Genome track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.